Risk factor
Low price volatility
Profitability factor
Undervalued vs peers
About
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals, Catalysis, Natural Resources, and Corporate. The Care Chemicals segment is composed of industrial and consumer specialties with a focus on applications and formulations for personal care, home care, crop solutions, paints and coatings, aviation, construction chemicals, and industrial lubricants. The Catalysis segment develops, manufactures, and sells catalyst products for the chemical, fuel, and automotive industries. The Natural Resources segment offers oil and mining services, functional minerals, and additives. The company was founded in 1995 and is headquartered in Muttenz, Switzerland.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA
Target Price
The average target price of CLN.SW is 11.7 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio